SGM
IRON icon

Seven Grand Managers’s Disc Medicine IRON Stock Holding History

Seven Grand Managers’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.56M Hold
35,000
– – 0.1% 130
2026
Q1 		$2.24M Hold
35,000
– – 0.15% 107
2025
Q4 		$2.78M Buy
+35,000
New +$2.96M 0.21% 99

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Seven Grand Managers's IRON Position: Q2 2026 in Review

Seven Grand Managers held its Disc Medicine (IRON) position steady in Q2 2026 at 35,000 shares worth $2.56M. The position accounts for 0.1% of the portfolio, ranked #130.

Seven Grand Managers first reported a position in IRON in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.78M in Q4 2025. 216 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Seven Grand Managers held 35,000 shares of Disc Medicine worth $2.56M as of Q2 2026.
  • Seven Grand Managers left its Disc Medicine share count unchanged in Q2 2026.
  • Disc Medicine made up 0.1% of Seven Grand Managers's portfolio in Q2 2026, its #130 holding.
  • Seven Grand Managers first reported a position in Disc Medicine in Q4 2025 and has held it in 3 quarters since.
  • Seven Grand Managers's Disc Medicine position peaked at $2.78M in Q4 2025.
  • 216 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Seven Grand Managers's 13F filing for Q2 2026, filed 14 Aug 2026.